Assessment of TP53 functionality in chronic lymphocytic leukaemia by different assays; an ERIC-wide approach-Reference-Cited by-同舟云学术

Assessment of TP53 functionality in chronic lymphocytic leukaemia by different assays; an ERIC-wide approach

Published:2014-06-30 Issue:4 Volume:167 Page:565-569
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

te Raa G. Doreen¹²,Malčiková Jitka³⁴,Mraz Marek³⁴,Trbusek Martin³⁴,Le Garff-Tavernier Magali⁵,Merle-Béral Hélène⁵,Greil Rudolf⁶,Merkel Olaf⁶⁷,Pospíšilová Sarka³⁴,Lin Ke⁸,Pettitt Andrew R.⁸,Stankovic Tatjana⁹,van Oers Marinus H.¹¹⁰,Eldering Eric²¹⁰,Stilgenbauer Stephan¹¹,Zenz Thorsten⁷¹²,Kater Arnon P.¹²¹⁰,

Affiliation:

1. Department of Haematology; Academic Medical Centre; Amsterdam The Netherlands

2. Laboratory of Exp. Immunology; Academic Medical Centre; Amsterdam The Netherlands

3. CEITEC; Centre of Molecular Medicine; Masaryk University; Brno Czech Republic

4. Department of Haematology and Oncology; Medical Faculty MU and University Hospital; Brno Czech Republic

5. AP-HP; Service d'Hématologie Biologique; Hopital Pitié-Salpêtrière; Paris France

6. IIIrd Medical department; Paracelsus Medical University Salzburg; Salzburg Austria

7. Department of Translational Oncology; National Centre for Tumour Diseases (NCT); German Cancer Research Centre (DKFZ); Heidelberg Germany

8. Department of Molecular and Clinical Cancer Medicine; University of Liverpool; Liverpool UK

9. School of Cancer Sciences; University of Birmingham; Birmingham UK

10. LYMMCARE (Lymphoma and Myeloma Centre); Academic Medical Centre; Amsterdam The Netherlands

11. Department of Internal Medicine III; University of Ulm; Ulm Germany

12. Department of Medicine V; University Hospital Heidelberg; Heidelberg Germany

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.13006/fullpdf

Reference10 articles.

1. microRNA-34a expression correlates with MDM2 SNP309 polymorphism and treatment-free survival in chronic lymphocytic leukemia;Asslaber;Blood,2010

2. Genomic aberrations and survival in chronic lymphocytic leukemia;Dohner;The New England Journal of Medicine,2000

3. Functional assessment of p53 in chronic lymphocytic leukemia;Garff-Tavernier;Blood Cancer Journal,2011

4. Functional analysis of the ATM-p53-p21 pathway in the LRF CLL4 trial: blockade at the level of p21 is associated with short response duration;Lin;Clinical Cancer Research,2012

5. Monoallelic and biallelic inactivation of TP53 gene in chronic lymphocytic leukemia: selection, impact on survival, and response to DNA damage;Malcikova;Blood,2009

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting p53 in chronic lymphocytic leukemia;Expert Opinion on Therapeutic Targets;2020-10-19

2. Assessing prognosis of chronic lymphocytic leukemia using biomarkers and genetics;Expert Opinion on Orphan Drugs;2020-08-16

3. TP53 dysfunction in chronic lymphocytic leukemia: clinical relevance in the era of B-cell receptors and BCL-2 inhibitors;Expert Opinion on Investigational Drugs;2020-06-27

4. MicroRNA miR-34a downregulates FOXP1 during DNA damage response to limit BCR signalling in chronic lymphocytic leukaemia B cells;Leukemia;2018-08-15

5. Ability to downregulate the level of cyclin-dependent kinase inhibitor p27Kip1 after DNA damage is retained in chronic lymphocytic leukemia cells with functional ATM/p53 signaling pathway;Leukemia & Lymphoma;2016-06-07